# Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer

> **NCT01098357** · PHASE1,PHASE2 · COMPLETED · sponsor: **Virchow Group** · enrollment: 192 (actual)

## Conditions studied

- Diabetic Foot Ulcers

## Interventions

- **DRUG:** Biochaperone PDGF-BB Low dose
- **DRUG:** Biochaperone PDGF-BB High dose
- **DRUG:** Regranex
- **DRUG:** Biochaperone PDGF-BB Very Low Dose

## Key facts

- **NCT ID:** NCT01098357
- **Lead sponsor:** Virchow Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-02
- **Final completion:** 2011-09
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2014-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01098357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01098357, "Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01098357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*